Dr. Hamilton on the Complex Treatment Algorithm for HER2+ Breast Cancer

Dr. Hamilton on Adjuvant Therapy for HER2+ Breast CancerПодробнее

Dr. Hamilton Discusses Challenges With Approved Treatments for HER2-Positive Breast CancerПодробнее

Dr. Hamilton on the Evolution of Treatment in HER2+ Breast CancerПодробнее

Dr. Erika P. Hamilton on The Shifting Treatment Paradigm in HER2-Positive Breast CancerПодробнее

Dr. Hamilton on Extended Adjuvant Therapy for HER2+ Breast CancerПодробнее

Dr. Hamilton on Recent Advances in HER2+ Breast CancerПодробнее

Dr. Hamilton on Overcoming Resistance to HER2-Targeted Therapy in Breast CancerПодробнее

HER2 Positive Breast Cancer Algorithm - OncBrothers (Rohit & Rahul Gosain) w/ Dr. Erika HamiltonПодробнее

Dr Hamilton on Implications of DESTINY-Breast06 on the HER2-Low Breast Cancer ParadigmПодробнее

Dr. Hamilton on the Optimal Duration of Trastuzumab in HER2+ Breast CancerПодробнее

2nd line treatment options for HR+ breast cancer.Подробнее

Dr. Hamilton on the FDA Approval of Tucatinib in HER2+ Breast CancerПодробнее

Treatment Options for HER2+ Breast Cancer: A Comprehensive GuideПодробнее

Dr. Hamilton on Research Needed in HER2-Positive Breast CancerПодробнее

Dr. Hamilton on Using pCR to Classify Risk in HER2+ Breast CancerПодробнее

Grand Rounds | Dr. E. Hamilton, M D: Evolving Management of HER2MBCПодробнее

Dr. Hamilton on the DESTINY-Breast01 Trial in HER2+ Breast CancerПодробнее

Dr. Hamilton Discusses the KATHERINE Trial in HER2+ Breast CancerПодробнее

Metastatic Breast Cancer: Leveraging Clinical Pathways to Navigate a Complex Treatment Landscape:Подробнее